| Patents for A01K 67 - Rearing or breeding animals, not otherwise provided for; New breeds of animals (34,042) |
|---|
| 01/15/2004 | WO2004005548A2 A method for discovery of human genes associated with viral hepatitis infection |
| 01/15/2004 | WO2004005474A2 A robust, inducible cardiac preferred expression system for transgenesis |
| 01/15/2004 | WO2004004785A1 Mchks as modifiers of the chk1 pathway and methods of use |
| 01/15/2004 | WO2004004451A1 Methods of screening compounds for grk6 modulating activity |
| 01/15/2004 | WO2004004447A2 Agouti-related protein deficient cells, non-human transgenic animals and methods of selecting compounds which regulate energy metabolism |
| 01/15/2004 | WO2003023048A3 METHODS FOR DIAGNOSING AND TREATING DISEASES AND CONDITIONS ASSOCIATED WITH PROTEIN KINASE C$g(l) |
| 01/15/2004 | WO2003014383A3 Phenotypic effects of ubiquinone deficiencies and methods of screening thereof |
| 01/15/2004 | WO2002072023A3 Production of high levels of transgenic factor viii with engineered stability, and its therapeutic uses |
| 01/15/2004 | WO2002061037B1 Administration of nucleic acid sequence to female animal |
| 01/15/2004 | US20040010814 Comprises nucleotide sequences coding kinases for developing contraceptives and controlling sex determination in animals |
| 01/15/2004 | US20040010813 Comprises nucleotide sequences capable of heart specific transcription for treating cardiomyopathies and cardiovascular disorders; anticardiopathic agents; drug screening |
| 01/15/2004 | US20040010811 Mixture comprising modulator for cancer activity; anticarcinogenic agents; tumor diagnosis; immunotherapy |
| 01/15/2004 | US20040010810 Producing xenogeneic monocolnal antibody for diagnosis and treatment of cancer, inflammation, allergies and asthma, autoimmune and cardiovascular diseases; immunotherapy |
| 01/15/2004 | US20040010042 Method for preventing decrease of breast milk amount in mammals |
| 01/15/2004 | US20040009901 Identifying and administering an agent that enhances NADPH oxidase activity; diagnosing an autoimmune condition accompanied by NADPH oxidase deficiency |
| 01/15/2004 | US20040009505 A pair of genetic engineered primers for the mutagenic amplification, therapeutic treatment |
| 01/15/2004 | CA2491687A1 A robust, inducible cardiac preferred expression system for transgenesis |
| 01/15/2004 | CA2491286A1 Methods of screening compounds for grk6 modulating activity |
| 01/15/2004 | CA2488725A1 Agouti-related protein deficient cells, non-human transgenic animals and methods of selecting compounds which regulate energy metabolism |
| 01/14/2004 | EP1380304A2 Process for the improvement of spermatozoa fertilization activity |
| 01/14/2004 | EP1380206A1 Aquaculture of marine worms |
| 01/14/2004 | EP1380205A1 Experimental animals for evaluation of therapeutic effects on corneal epithelial damages |
| 01/14/2004 | EP1379882A1 Diagnostic and therapeutic use of a nuclear restricted protein for alzheimer's disease and related neurodegenerative disorders |
| 01/14/2004 | EP1379869A1 Method for therapeutically treating a clinically recognized form of cardiopathology in a living mammal |
| 01/14/2004 | EP1379701A2 Elimination of endogenous porcine retrovirus |
| 01/14/2004 | EP1379677A2 Production of high levels of trangenic factor ix without gene rescue, and its therapeutic uses |
| 01/14/2004 | EP1379665A2 Gene therapy with chimeric oligonucleotides delivered by a method comprising a step of iontophoresis |
| 01/14/2004 | EP1379656A2 G-protein coupled receptor molecules and uses thereof |
| 01/14/2004 | EP1379652A2 Human nucleic acid molecules and polypeptides encoding a human ion channel expressed in spinal cord and brain |
| 01/14/2004 | EP1379649A2 Calcium binding proteins |
| 01/14/2004 | EP1379648A1 Full-length human cdnas encoding potentially secreted proteins |
| 01/14/2004 | EP1379637A2 Nucleic acid molecules encoding a transmembran serine protease 9, the encoded polypeptides and methods based thereon |
| 01/14/2004 | EP1379275A2 Chronic obstructive pulmonary disease-related immunglobulin derived proteins, compositions, methods and uses |
| 01/14/2004 | EP1379125A1 Transgenic animals expressing antibodies specific for genes of interest and uses thereof |
| 01/14/2004 | CN2598349Y Device for treating aquatic animal cytula under analogue weightlessness state |
| 01/14/2004 | CN2598348Y Multitaste dog biting gum |
| 01/14/2004 | CN1468309A Anti-il-12 antibodies, compositions, methods and uses |
| 01/14/2004 | CN1468306A Schizophrenia related gene and protein |
| 01/14/2004 | CN1468250A Production of humanized antibodies in transgenic animals |
| 01/14/2004 | CN1134211C Method for localizing allantoic fluid of avian eggs |
| 01/13/2004 | US6677500 Ungulates expressing exogenous IGF-I in their milk |
| 01/13/2004 | US6677145 Isolating a nucleotide sequence having specific sequence, constructing a vector consists of an isolated nucleotide sequence operably linked to a promoter, introducing the vector into host cell for expression of elongase enzyme |
| 01/13/2004 | US6676938 Vaccine formulations comprising antiidiotypic antibodies which immunologically mimic group B streptococcal carbohydrates |
| 01/12/2004 | CA2403235A1 Modulation of cytochrome p450 reductase activity |
| 01/08/2004 | WO2004003209A2 Nucleic acid isolated from the 5' non translated region (5'ntr) end of the human fgf-1 gene having ires activity |
| 01/08/2004 | WO2004003198A1 Method of examining allergic disease and drug for treating the same |
| 01/08/2004 | WO2004003157A2 Gene regulation in transgenic animals using a transposon-based vector |
| 01/08/2004 | WO2004003156A2 Il-21 as a regulator of immunoglobin production |
| 01/08/2004 | WO2003007800A3 Methods for diagnosing and treating diseases and conditions of the digestive system and cancer |
| 01/08/2004 | WO2003000859A3 G-protein coupled receptors |
| 01/08/2004 | WO2002099036A3 Inhibition of neurodegeneration |
| 01/08/2004 | WO2002059310A3 Polynucleotides encoding cellular transporters and methods of use thereof |
| 01/08/2004 | WO2002053596A3 Antibodies to insulin-like growth factor i receptor |
| 01/08/2004 | US20040006782 Non-human mammal mutant for expression of the alpha6 subunit of the nicotinic acetylcholine receptor, and use for screening substances that can interact with said receptor |
| 01/08/2004 | US20040006780 VEGF-modulated genes and methods employing them |
| 01/08/2004 | US20040006779 Antibodies against gene products related to werner's syndrome |
| 01/08/2004 | US20040006778 Comprises heat resistant polypeptide for preparing pharmaceuticals; drug biosynthesis; side effect reduction |
| 01/08/2004 | US20040006776 Transgenic production of antibodies in milk |
| 01/08/2004 | US20040006775 Invention provides mice having reduced constitutive androstane receptor activity and mice expressing a human CAR receptor |
| 01/08/2004 | US20040006215 Human monoclonal antibodies against CD30 |
| 01/08/2004 | US20040005666 Methods and reagents for modulating cholesterol levels |
| 01/08/2004 | US20040005629 Natural ligand of orphan G protein coupled receptor GPR86 and methods of use |
| 01/08/2004 | US20040005619 Diagnosing osteoporosis and paget's diseases via identifying variable numbers of tandem repeats in allelic sequences coding parathyroid hormone related peptide (PTHrP) |
| 01/08/2004 | US20040005604 Comprises nucleotide sequences coding enzymatic polypeptide for degumming oil and food processing; antisense therapy |
| 01/08/2004 | US20040005576 Comprises polypeptides for diagnosing, prognosing and preventing cancer, nervous system, developmental and metabolic disorders |
| 01/08/2004 | CA2490017A1 Nucleic acid isolated from the 5' non translated region (5'ntr) end of the human fgf-1 gene having ires activity |
| 01/07/2004 | EP1377678A2 Diagnostic and therapeutic use of a caveolae-associated integral membrane protein for alzheimer's disease and related neurodegenerative disorders |
| 01/07/2004 | EP1377159A1 Products and methods for improving animal dental hygiene |
| 01/07/2004 | CN1465240A Method for scaled breeding cattail mite and application in biological preventing and controlling pest-insect |
| 01/07/2004 | CN1465239A Scaled breeding for semanotus bifasciatus and application in biological preventing and controlling pest-insect |
| 01/07/2004 | CN1465238A Method for breeding new strain chicken with yellow (white) tibiala and complete set application |
| 01/07/2004 | CN1465237A Method for layered raising broiler and pig in same shed in the northern cold area |
| 01/07/2004 | CN1465236A System engineering for ecological cultivating live pig and earthworm and comprehensively developing and utilizing them |
| 01/07/2004 | CN1133367C Backcross method of improving sex-linked balanced lethal line of bombyx mori |
| 01/06/2004 | US6673986 Transgenic mouse; deactivated endogenous immunoglobulin heavy chain loci; gene expression |
| 01/06/2004 | US6673768 Transgenic animal models for cardiac hypertrophy and methods of use thereof (treating) |
| 01/06/2004 | US6673600 Transgenic C. elegans as a model organism for investigations on Alzheimer's disease |
| 01/06/2004 | US6673564 Detecting modulators of polypeptide activity in cell; obtain cell, incubate with modulator, monitor cellular activity and compare to control |
| 01/02/2004 | EP1375654A2 Transgenic and cloned mammals |
| 01/02/2004 | EP1375516A2 Method of production of a recombinant polypeptide of the LSR receptor |
| 01/02/2004 | EP1374693A2 Method for preventing decrease of breast milk amount in mammals |
| 01/02/2004 | EP1374672A1 Drosophila strain carrying bradeion gene(s) transferred thereinto |
| 01/02/2004 | EP1373890A2 Means for the identification of compounds capable of inhibiting karap-transduced signals |
| 01/02/2004 | EP1373545A2 Mch1r deficient mice |
| 01/02/2004 | EP1373535A2 Improved gene expression |
| 01/02/2004 | EP1373531A1 Method of encoding information in nucleic acids of a genetically engineered organism |
| 01/02/2004 | EP1373528A1 Novel expression vectors |
| 01/02/2004 | EP1373519A2 New elongase gene and production of delta-9-polyunsaturated fatty acids |
| 01/02/2004 | EP1373498A2 Animal tissue with carbohydrate antigens compatible for human transplantation |
| 01/02/2004 | EP1373493A1 Coagulation factor vii derivatives |
| 01/02/2004 | EP1373477A2 A novel virus (cryptovirus) within the rubulavirus genus and uses therefor |
| 01/02/2004 | EP1373473A1 Gene targeting methods and vectors |
| 01/02/2004 | EP1373318A2 Neutralizing human monoclonal antibodies against hiv-1, their production and uses |
| 01/02/2004 | EP1373317A2 Nuclear hormone receptor ligand binding domains |
| 01/02/2004 | EP1373316A2 Nuclear hormone receptor ligand binding domain |
| 01/02/2004 | EP1373315A2 Nuclear hormone receptor ligand binding domain |
| 01/02/2004 | EP1373297A2 A lac operator-repressor system |
| 01/02/2004 | EP1372736A2 Anti-neovasculature preparations for cancer |
| 01/02/2004 | EP1372380A2 Method for determining the therapeutic efficacy of a medicament against parkinson's disease and/or parkinson syndrome using an fri/fri mouse as a model |
| 01/01/2004 | US20040003425 Nav2 channel gene-deficient non-human animals |